Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Zosurabalpin
open-in-new
<h2 id="see-also">See also</h2> <ul><li><a href="/facts/Clovibactin/XseAQSNL">Clovibactin</a></li> <li><a href="/facts/Novobiocin/PXYRaXsu">Novobiocin</a></li> <li><a href="/facts/Teixobactin/lxog37CI">Teixobactin</a></li></ul> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>Zampaloni C, Mattei P, Bleicher K, Winther L, Thäte C, Bucher C, et al. (January 2024). "A novel antibiotic class targeting the lipopolysaccharide transporter". Nature. 625 (7995): 566–571. doi:10.1038/s41586-023-06873-0. PMC 10794144. PMID 38172634. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794144" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794144</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>Pahil KS, Gilman MS, Baidin V, Clairfeuille T, Mattei P, Bieniossek C, et al. (January 2024). "A new antibiotic traps lipopolysaccharide in its intermembrane transporter". Nature. 625 (7995): 572–577. doi:10.1038/s41586-023-06799-7. PMC 10794137. PMID 38172635. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794137" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10794137</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>US 20190321440A1, Bleicher K, Cheang D, Di Giorgio P, Hu T, Jenny C, Mattei P, Schmitz P, Stoll T, "Peptide macrocycles against acinetobacter baumannii.", issued 21 November 2023, assigned to Hoffmann La Roche Inc. <a href="https://patents.google.com/patent/US20190321440A1" target="_blank">https://patents.google.com/patent/US20190321440A1</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>Erbetti I, Ferrari L, Ortombina A, Savoia P, Felici A, Bissantz C, Zampaloni C (December 2023). "2109. In vitro and in vivo Killing Kinetics of Zosurabalpin (RG6006) Against Acinetobacter baumannii.". Open Forum Infectious Diseases. Vol. 10. Oxford University Press. doi:10.1093/ofid/ofad500.1733. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Theuretzbacher U (October 2023). "Evaluating the innovative potential of the global antibacterial pipeline". Clinical Microbiology and Infection. doi:10.1016/j.cmi.2023.09.024. PMID 37805036. S2CID 263722286. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> </ol>